Femtogenix Limited
Records under this name other than patents Femtogenix Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Femtogenix Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,399,970 | Pyrridinobenzodiazepine and benzopyrridodiazecine compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,975,072 | SUBSTITUTED 6a,7,8,9,10,12-Hexahydrobenzo[e]PYRIDO[1,2-a][1,4]DIAZEPINES AS ANTI-PROLIFERATIVE AGENTS Formerly held In force · High confidence | In force | High confidence | |
| US 10,975,074 | Anti-liferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,912,700 | Anti-proliferative agents comprising substituted benzo[e]pyrido[1,2-a][1,4]diazepines Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,466,032 | Cytotoxic Agents Formerly held Lapsed on the fee record Ended Oct 11, 2026 · High confidence | Lapsed on the fee record | Ended Oct 11, 2026 | High confidence |
| US 9,999,625 | Pyrrolobenzodiazepine compounds Formerly held Lapsed on the fee record Ended Jun 19, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 19, 2026 | USPTO record |